Skip to main content
Nature Portfolio logoLink to Nature Portfolio
. 2022 Apr 21;28(5):1095–1096. doi: 10.1038/s41591-022-01817-z

Author Correction: A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus

Allison August 1,, Husain Z Attarwala 1, Sunny Himansu 1, Shiva Kalidindi 1, Sophia Lu 1, Rolando Pajon 1, Shu Han 1, Jean-Michel Lecerf 1, Joanne E Tomassini 1, Marjie Hard 1, Leon M Ptaszek 2, James E Crowe 3, Tal Zaks 1
PMCID: PMC9117134  PMID: 35449420

Correction to: Nature Medicine 10.1038/s41591-021-01573-6, published online 9 December 2021.

In the version of this article initially published, there were errors in the inset graph to Fig. 2a, where the inset had the graph lines and symbols for the 0.3 mg kg–1 and the 0.6 mg kg–1 switched, and the wrong data were shown for the 0.6 mg kg–1 in the inset. The labels and plots have been corrected in the HTML and PDF versions of the article. The original and corrected Fig 2a graphs are shown below.

Fig. 2.

Fig. 2

Original and corrected.


Articles from Nature Medicine are provided here courtesy of Nature Publishing Group

RESOURCES